Serina Therapeutics, Inc. (SER) › Total LiabilitiesSerina Therapeutics, Inc. (SER) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $1.31M2018: $2.44M2019: $4.83M2020: $9.32M2021: $15.03M2022: $20.56M2023: $4.86M2024: $6.22M2025: $6.99M$6.99M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$6.99M+12.4%2024$6.22M+28.0%2023$4.86M-76.4%2022$20.56M+36.8%2021$15.03M+61.2%2020$9.32M+93.2%2019$4.83M+97.7%2018$2.44M+86.0%2017$1.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share